LetsGetChecked
$1Bpaper valuation
// OVERVIEW
LetsGetChecked built a $1 billion at-home diagnostic testing business by selling convenience to people who would rather mail bodily fluids to a lab than sit in a waiting room for fifteen minutes. The pandemic proved the model worked at scale — the question is whether anyone still cares now that CVS offers the same service without the shipping delay.
// HQ
Dublin, Ireland
// STATUS
PRIVATE
// FOUNDED
2015
// TIER
The Unicorn Herd · $1B – $9.9B
// PRIMARY SECTOR
diagnostics
// FOUNDERS
// FUNDING ROUNDS
// SECTORS SERVED
// TECHNOLOGY
At-home sample collection kits paired with lab partnerships and telehealth consultations. The core technology is logistics and lab coordination, not diagnostics — LetsGetChecked does not run the tests, does not employ the physicians reviewing results, and does not manufacture the collection devices.
// WOWLS ASSESSMENT
LetsGetChecked raised $270 million through 2021 when at-home testing was a pandemic necessity and achieved unicorn status by convincing investors that consumer preference for convenience would outlast COVID-19 urgency. The Irish company operates in sexual health, fertility, wellness, and general health screening — categories where traditional providers like Quest Diagnostics and LabCorp have launched competing direct-to-consumer services with better brand recognition and insurance integration. Revenue figures remain undisclosed but the 2021 valuation assumed sustained growth from a temporary behavioral shift that has largely reverted. Walgreens, CVS, and Everlywell offer comparable services with retail distribution advantages LetsGetChecked cannot match through e-commerce alone.
// WHY WOWLS HUNTS THIS
The 2021 valuation priced in a permanent shift to at-home diagnostics that never materialized beyond COVID testing. Quest Diagnostics and LabCorp launched DTC services with better insurance coverage and LetsGetChecked has not disclosed revenue growth since.
// VALUATION NOTE
Valuation based on 2021 Series D. No subsequent funding rounds or revenue disclosure to validate sustained growth post-pandemic.
VERDICT: TERMINAL HYPE — THE $1 BILLION VALUATION ASSUMED PEOPLE WOULD PERMANENTLY PREFER MAILING BLOOD SAMPLES OVER WALKING INTO A WALGREENS, AND THAT ASSUMPTION EXPIRED IN 2022
// PACK DEBATE
// PACK DEBATE — be the first to weigh in
Google account required — no spam, no nonsense
// LOADING INTEL…
// BROADCAST INTEL
// SIMILAR TARGETS
// INTEL UPDATED: MAY 2026
// INTELLIGENCE DISCLAIMER: Assessments represent editorial opinion based on publicly available data including filings, press reports, and market data as of the date shown. Valuations are approximate. Not financial or investment advice.
// FULL NETWORK ACCESS
🚀 Founder Briefing: Instantly sort investors by Sector, Stage, & Round — direct links to websites for all 1,030 unicorns & backing VCs included.
Don't just track LetsGetChecked.
Master the entire 1,030 unicorn company intelligence network.
Stop analyzing tech monopolies one page at a time. Instantly filter, sort, and isolate the exact venture capital firms, angel investors, and corporate funds backing your specific market vertical. Find investors that fit your sector and deploy your pitch with direct outbound links to every target asset in the database — 1,030 targets total.
Acquire Intel →// 5 TIERS · PAYPAL SECURED
// ENGAGE THE FULL ARSENAL
Done reading on LetsGetChecked?
Unlock the entire 1,030-company hitlist and 1,030 investor contacts.
Full structural breakdowns. Founder dossiers. VC outreach data. Threat-level intel updated continuously.
→ Deploy 5-Tier Order Form// ARBAN · ZUUN · MINGHAN · TUMEN · KHAN